Cargando…
Twenty-first century oocyte cryopreservation—in vitro maturation of immature oocytes from ovarian tissue cryopreservation in cancer patients: A systematic review
OBJECTIVES: Our review aimed to consolidate the latest update on the application of in vitro maturation among immature oocyte harvest in combination with ovarian tissue cryopreservation known as ovarian tissue oocyte–in vitro maturation. METHODS: A thorough search for relevant studies was conducted...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393350/ https://www.ncbi.nlm.nih.gov/pubmed/35983837 http://dx.doi.org/10.1177/17455057221114269 |
_version_ | 1784771254426796032 |
---|---|
author | Mohd Faizal, Ahmad Sugishita, Yodo Suzuki-Takahashi, Yuki Iwahata, Hideyuki Takae, Seido Horage-Okutsu, Yuki Suzuki, Nao |
author_facet | Mohd Faizal, Ahmad Sugishita, Yodo Suzuki-Takahashi, Yuki Iwahata, Hideyuki Takae, Seido Horage-Okutsu, Yuki Suzuki, Nao |
author_sort | Mohd Faizal, Ahmad |
collection | PubMed |
description | OBJECTIVES: Our review aimed to consolidate the latest update on the application of in vitro maturation among immature oocyte harvest in combination with ovarian tissue cryopreservation known as ovarian tissue oocyte–in vitro maturation. METHODS: A thorough search for relevant studies was conducted via PubMed, Google Scholar, EMBASE, and clinical.gov databases up to December 2020. The primary outcome was the oocyte maturation rate, which measured the number of immature oocytes (geminal vesicle stage) that progressed to mature oocytes (meiosis II stage) following in vitro maturation. The secondary outcomes were the fertilization rate following intracytoplasmic sperm injection/in vitro fertilization of these oocytes for the embryo cryopreservation cohort. Our review included pre-pubertal girls and women with cancer who underwent ovarian tissue oocyte–in vitro maturation as fertility preservation. RESULTS: The primary search identified 207 studies. Twelve manuscripts were selected for inclusion in our review following duplication assessment, title and abstract screening, and full-text evaluation tailored to our inclusion criteria. All the population belonged to a cancer group and underwent concurrent ovarian tissue oocyte–in vitro maturation. A total of 5724 immature oocytes were obtained following ovarian tissue cryopreservation. Approximately 33.84% of the immature oocytes successfully matured via in vitro maturation, which were cryopreserved as oocytes or fertilized as embryos and subsequently stored for future use. CONCLUSION: Our review proposed the potential application of ovarian tissue oocyte–in vitro maturation in increasing the number of mature oocytes. The acceptable improvement in oocyte maturation rate following in vitro maturation indicates that improving oocyte outcomes is an excellent cost-effective strategy for fertility preservation among women with cancer. |
format | Online Article Text |
id | pubmed-9393350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-93933502022-08-23 Twenty-first century oocyte cryopreservation—in vitro maturation of immature oocytes from ovarian tissue cryopreservation in cancer patients: A systematic review Mohd Faizal, Ahmad Sugishita, Yodo Suzuki-Takahashi, Yuki Iwahata, Hideyuki Takae, Seido Horage-Okutsu, Yuki Suzuki, Nao Womens Health (Lond) Onco-Fertility: Bridging the Gap Between Cancer and Reproductive Health OBJECTIVES: Our review aimed to consolidate the latest update on the application of in vitro maturation among immature oocyte harvest in combination with ovarian tissue cryopreservation known as ovarian tissue oocyte–in vitro maturation. METHODS: A thorough search for relevant studies was conducted via PubMed, Google Scholar, EMBASE, and clinical.gov databases up to December 2020. The primary outcome was the oocyte maturation rate, which measured the number of immature oocytes (geminal vesicle stage) that progressed to mature oocytes (meiosis II stage) following in vitro maturation. The secondary outcomes were the fertilization rate following intracytoplasmic sperm injection/in vitro fertilization of these oocytes for the embryo cryopreservation cohort. Our review included pre-pubertal girls and women with cancer who underwent ovarian tissue oocyte–in vitro maturation as fertility preservation. RESULTS: The primary search identified 207 studies. Twelve manuscripts were selected for inclusion in our review following duplication assessment, title and abstract screening, and full-text evaluation tailored to our inclusion criteria. All the population belonged to a cancer group and underwent concurrent ovarian tissue oocyte–in vitro maturation. A total of 5724 immature oocytes were obtained following ovarian tissue cryopreservation. Approximately 33.84% of the immature oocytes successfully matured via in vitro maturation, which were cryopreserved as oocytes or fertilized as embryos and subsequently stored for future use. CONCLUSION: Our review proposed the potential application of ovarian tissue oocyte–in vitro maturation in increasing the number of mature oocytes. The acceptable improvement in oocyte maturation rate following in vitro maturation indicates that improving oocyte outcomes is an excellent cost-effective strategy for fertility preservation among women with cancer. SAGE Publications 2022-08-19 /pmc/articles/PMC9393350/ /pubmed/35983837 http://dx.doi.org/10.1177/17455057221114269 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Onco-Fertility: Bridging the Gap Between Cancer and Reproductive Health Mohd Faizal, Ahmad Sugishita, Yodo Suzuki-Takahashi, Yuki Iwahata, Hideyuki Takae, Seido Horage-Okutsu, Yuki Suzuki, Nao Twenty-first century oocyte cryopreservation—in vitro maturation of immature oocytes from ovarian tissue cryopreservation in cancer patients: A systematic review |
title | Twenty-first century oocyte cryopreservation—in vitro maturation of
immature oocytes from ovarian tissue cryopreservation in cancer patients: A
systematic review |
title_full | Twenty-first century oocyte cryopreservation—in vitro maturation of
immature oocytes from ovarian tissue cryopreservation in cancer patients: A
systematic review |
title_fullStr | Twenty-first century oocyte cryopreservation—in vitro maturation of
immature oocytes from ovarian tissue cryopreservation in cancer patients: A
systematic review |
title_full_unstemmed | Twenty-first century oocyte cryopreservation—in vitro maturation of
immature oocytes from ovarian tissue cryopreservation in cancer patients: A
systematic review |
title_short | Twenty-first century oocyte cryopreservation—in vitro maturation of
immature oocytes from ovarian tissue cryopreservation in cancer patients: A
systematic review |
title_sort | twenty-first century oocyte cryopreservation—in vitro maturation of
immature oocytes from ovarian tissue cryopreservation in cancer patients: a
systematic review |
topic | Onco-Fertility: Bridging the Gap Between Cancer and Reproductive Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393350/ https://www.ncbi.nlm.nih.gov/pubmed/35983837 http://dx.doi.org/10.1177/17455057221114269 |
work_keys_str_mv | AT mohdfaizalahmad twentyfirstcenturyoocytecryopreservationinvitromaturationofimmatureoocytesfromovariantissuecryopreservationincancerpatientsasystematicreview AT sugishitayodo twentyfirstcenturyoocytecryopreservationinvitromaturationofimmatureoocytesfromovariantissuecryopreservationincancerpatientsasystematicreview AT suzukitakahashiyuki twentyfirstcenturyoocytecryopreservationinvitromaturationofimmatureoocytesfromovariantissuecryopreservationincancerpatientsasystematicreview AT iwahatahideyuki twentyfirstcenturyoocytecryopreservationinvitromaturationofimmatureoocytesfromovariantissuecryopreservationincancerpatientsasystematicreview AT takaeseido twentyfirstcenturyoocytecryopreservationinvitromaturationofimmatureoocytesfromovariantissuecryopreservationincancerpatientsasystematicreview AT horageokutsuyuki twentyfirstcenturyoocytecryopreservationinvitromaturationofimmatureoocytesfromovariantissuecryopreservationincancerpatientsasystematicreview AT suzukinao twentyfirstcenturyoocytecryopreservationinvitromaturationofimmatureoocytesfromovariantissuecryopreservationincancerpatientsasystematicreview |